We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

A collection of many different pills.
Industry Insight

Using AI To Get Medicines to Patients Faster

To find out more about AI in pharma, Technology Networks spoke with Roger Palframan, head of US Research and digital for Early Solutions at UCB.
Red and white and blue and white capsule drugs.
Industry Insight

Sourcing Chemistry From Inside Humans

In this interview, Dr. Jason Park, co-founder and CEO of Empress Therapeutics, tells us more about the Chemilogics platform and the benefits this approach to drug discovery can offer.
Human hand holding a variety of AI icons.
Industry Insight

The Ethical Implications of AI in Scientific Publishing

As the use of generative AI tools expands, and their potential in scientific research is better understood, there are ethical considerations to be made. Dr. Dror Kolodkin-Gal explores some of the issues and potential solutions.
Cancer seen in the lungs of a human torso
Industry Insight

Addressing One of the Most Common Dilemmas Faced by Oncologists

Technology Networks spoke to Dr. Ofer Sharon, CEO of OncoHost, to learn about the challenges in non-small cell lung cancer treatment and how proteomics-based analysis could enable personalized cancer treatments.
Small molecule closeup
Industry Insight

Confident Metabolite Identification for Meaningful Results in Multiomics Analyses

In this interview, Technology Networks spoke to Heiko Neuweger, director of Bioinformatics Life Science Mass Spectrometry Software R&D at Bruker, to learn about the importance of target compound annotation and identification, the advantages of integrating collision cross section (CCS) information into workflows and the benefits of CCS-Predict Pro.
Human hand holding a digital globe representing connectivity and digitization.
Industry Insight

Exploring Key Challenges in Life Science R&D

Technology Networks spoke to Dr. Markus Gershater to learn more about Synthace's Lab automation & experimentation in life science R&D 2023-2024 report, its findings and their significance.
Data and network icons in front of a group of people in discussion.
Industry Insight

How To Build a Data-Centric Future for Biotechnology

In this op-ed, Markus Gershater delves into different aspects of the data we’ll need to generate to help us truly understand the biological systems we deal with.
Two people in lab coats looking at an ACT label on a piece of analytical chemistry equipment.
Industry Insight

What Does Sustainability Accreditation Really Mean for Scientific Companies?

With growing sustainability demands, companies are looking for ways to demonstrate their green credentials. We spoke to Dr. Michael Frank to find out what ACT accreditation means for a company and why he thinks schemes like this are so important.
Scientists in a lab working at analytical machines while others analyse data at computers in the background.
Industry Insight

A New-Generation HPLC System Has Users at Its Heart

HPLC system manufacturers have been striving to improve usability, accessibility and help users improve their experimental outcomes. And what better way to do that than to involve the users themselves in that development process.
Quality written in white chalk on a blackboard.
Industry Insight

Maximizing Productivity in High-Volume QA/QC Labs

To learn more about the waters_connectTM System Monitoring Software and the benefits it offers, Technology Networks spoke to Dave Leitham.

Advertisement